Jeffrey Chodakewitz, EVP GMDA, CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,976 shares at $152.80 ($756K) on 2018-01-02, disclosed to the SEC on 2018-01-03.
Open-market sale of $756k VRTX by EVP GMDA, CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $149.65 | 300 | $45K | 5.9% |
| 2 | $150.87 | 675 | $102K | 13.5% |
| 3 | $150.87 | 675 | $102K | 13.5% |
| 4 | $152.06 | 1,600 | $243K | 32.2% |
| 5 | $152.80 | 863 | $132K | 17.5% |
| 6 | $152.80 | 863 |
| $132K |
| 17.5% |
| Total | $151.85 avg | 4,976 | $756K | 100% |
| Filing → |
| VRTX | SELL | 2018-02-05 | $782K | — | Filing → |
| VRTX | SELL | 2018-01-17 | $351K | — | Filing → |
| VRTX | SELL | 2017-11-06 | $1.5M | — | Filing → |